Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01546142 · ClinicalTrials.gov registry record · Phase 3
Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area
A Phase 3 study, sponsored by Kythera Biopharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 516
- Enrollment target
NCT01546142 is a Phase 3 study that has completed, run by Kythera Biopharmaceuticals. The registered enrollment target is 516 participants.
The verdict
NCT01546142, a Phase 3 study, has completed, sponsored by Kythera Biopharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 516 participants
- Enrollment target
Study Summary
To evaluate the safety and efficacy of deoxycholic acid injection in the reduction of submental fat (fat below the chin).
Interventions
- DRUG Placebo
- DRUG Deoxycholic acid injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 516 participants |
| Start Date | 2012-03 |
| Est. Completion | 2013-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01546142
The ClinicalTrials.gov registry entry for NCT01546142 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 516 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kythera Biopharmaceuticals, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01546142 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01546142 about?
NCT01546142 is a clinical study titled "Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area". To evaluate the safety and efficacy of deoxycholic acid injection in the reduction of submental fat (fat below the chin).
What is the current status of trial NCT01546142?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 516 participants. The study started on 2012-03. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01546142?
The interventions under investigation include: Placebo (DRUG), Deoxycholic acid injection (DRUG).
Who is sponsoring clinical trial NCT01546142?
This trial is sponsored by Kythera Biopharmaceuticals, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.